September 2017

28 September 2017 AstraZeneca presents first DEP® candidate as Bcl2/xL inhibitor

22 September 2017 DEP® docetaxel positive phase 1 results; phase 2 commences

August 2017

28 August 2017 Starpharma annual report and full year financial results

9 August 2017 Starpharma and Monash awarded STEM+ Business Fellowships

7 August 2017 Successful VivaGel® Phase 3 results and NDA planned for rBV

July 2017

4 July 2017 Shareholder Update July 2017

June 2017

14 June 2017 Sale of Agrochemicals Business Investor Presentation

14 June 2017 Starpharma sells Agrochemicals business to Agrium for $35M

6 June 2017 DEP® irinotecan outperforms irinotecan in multiple cancer models

April 2017

20 April 2017 AstraZeneca DEP® candidate advance triggers milestone to Starpharma

12 April 2017 Ansell launches VivaGel® condom in Canada

March 2017

30 March 2017 VivaGel® BV phase 3 trials for prevention of BV completed